Clinical trial · Interventional
Smartphone App for Cancer Medication Adherence
Trial of a Smartphone Application to Improve Medication Adherence Among Patients with Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
For this current proposal, the investigator will conduct a single-center prospective non-randomized pilot interventional study in patients with any stage and type of cancer who are either taking at least one OACD or are taking at least one oral medication for chronic condition management in conjunction with any cancer treatment. Primary Objective: To determine the feasibility of using a medication reminder application (Medisafe App) to improve medication adherence in cancer patients either receiving oral anticancer agents (OACDs) or receiving oral medications for chronic disease management (non-OACDs) in conjunction with non-oral cancer treatment. Secondary Objectives: To compare and characterize medication adherence before and after the 12-week intervention using the Voils Extent of Adherence Scale and the Medisafe App. Also to determine the acceptability, utility and patient engagement with the App, to evaluate changes in healthcare related quality of life before and after the intervention, and to explore behaviors, knowledge, attitudes and beliefs related to medication adherence using a semi-structured interview delivered over the telephone.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Carcinoma | Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Smartphone App | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Smartphone App Intervention
- description
- Cancer patients taking at least one oral anti-cancer drug or oral medication to manage a chronic condition in conjunction with any cancer treatment will receive messages through the Medisafe App.
- interventionNames
- Other: Smartphone App
Primary outcomes (1)
- measure
- Proportion of subjects enrolled that complete the 12-week intervention and assessments
- timeFrame
- 12 weeks
- description
- To determine the feasibility of using a medication reminder application (Medisafe App) to improve medication adherence in cancer patients. Feasibility defined as completing the 12-week intervention and the endpoint assessments. Patients will be tallied.
Secondary outcomes (6)
- measure
- Change in mean score on the Voils Extent of Adherence Scale for oral caner therapy use between baseline and 12 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any type/stage cancer * Patients must be taking either: * at least one oral anti-cancer drug (OACD) or * at least one oral medication (non-OACD) for management of a chronic condition in addition to receiving non-oral cancer treatment * Patients must have access to a mobile phone or tablet that can download the Medisafe App. (ie apple/android) * Subjects must be able to complete self-administered questionnaires in English or Spanish. * Co-enrollment in trials involving pharmacologic therapy is allowed. Exclusion Criteria: * Inability to provide informed consent
References
Publications (0)
Data not yet available